Product
BMS-986340
1 clinical trial
12 indications
Indication
Cervical CancerIndication
Colorectal CancerIndication
Lung CancerIndication
Squamous Cell Carcinoma of Head and NeckIndication
cancerIndication
Renal CellIndication
Bladder CancerIndication
Pancreatic adenocarcinomaIndication
MelanomaIndication
Ovarian CancerIndication
Breast NeoplasmsClinical trial
A Phase 1/2 Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2025-04-10